6-K ·Filed May 12, 2026

RDY

DR REDDYS LABORATORIES LTD
NEUTRAL
Impact 2/10
Horizondays Processed4mo ago SEC0001575872-26-000297
Notable filing: 6-K
Actionable Insight • Neutral

The filing is routine. Investors seeking details on Q4 results should listen to the earnings call recording. No immediate trading action is warranted based on this disclosure alone.

DirectionNeutral
Confidencemedium
Horizondays
Final — all horizons settled through T+60d ⚠ clustered
RDY ▼ -2.81% at T+60d
NEUTRAL call ✗ call lost -2.81% · α vs SPY -7.19% · entry $12.46 → $12.11
Entry anchored
May 12, 02:53 PM ET
via exchange tick
T+1d
+4.25%
call +4.25% · α +3.68%
$12.99
settled 5mo ago
T+5d
+9.15%
call +9.15% · α +9.07%
$13.60
settled 5mo ago
T+20d
+6.74%
call +6.74% · α +8.47%
$13.30
settled 4mo ago
T+60d
-2.81%
call -2.81% · α -7.19%
$12.11
settled 8w ago

Price Chart

Loading chart...

Executive Summary

Dr. Reddy's Laboratories filed a 6-K providing a link to the audio recording of its Q4 FY2026 earnings call held on May 12, 2026. This is a routine disclosure with no new financial data beyond what was already announced. The filing has no material impact on the company's stock price.

Key Facts

  • Filed Form 6-K on May 12, 2026, with Exhibit 99.1 containing a link to the audio recording of the Q4 FY2026 earnings call.
  • The earnings call was conducted on May 12, 2026, for the quarter ended March 31, 2026.
  • No financial figures or material updates are provided in the filing; it is purely a disclosure of the recording availability.

Financial Impact

Not specified

Risk Factors

  • No material risks identified from this filing.

Market Snapshot

Exchange
NYSE
Sector
Pharmaceutical Preparations
Analyst Consensus
50% bullish (44 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001575872-26-000297
Document: 0001575872-26-000297-index.html0001575872-26-000297
Document: 0001575872-26-000297.txt0001575872-26-000297
51 reports for RDY
Performance horizon
67% Hit rate 6 of 9 directional calls best @ T+20▲ +23.28%Jun 26, 2026
Filters
Rows
Reports for RDY — sortable, filterable
TypeNow
Sep 14, 2026
18d ago
6-K
NEUTRAL ★ 3/10
$11.91 $11.55▼ −3.02%▼ −2.56%$12.25 (+2.85%)
Sep 10, 2026
22d ago
6-K
NEUTRAL ★ 5/10
$11.71 $11.90▲ +1.62%▲ +0.77%$12.25 (+4.61%)
Sep 10, 2026
22d ago
6-K
NEUTRAL ★ 2/10
$11.71 $11.90▲ +1.62%▲ +0.77%$12.25 (+4.61%)
Aug 26, 2026
5w ago
6-K
NEUTRAL ★ 2/10
$12.22 $12.16▼ −0.49%▼ −1.15%$12.25 (+0.25%)
Aug 17, 2026
6w ago
6-K
MIXED ★ 5/10
$12.11 $12.15▲ +0.33%▲ +1.01%$12.25 (+1.16%)
Aug 13, 2026
7w ago
6-K
NEUTRAL ★ 3/10
$12.42 $12.27▼ −1.21%▼ −1.01%$12.25 (−1.37%)
Aug 10, 2026
7w ago
6-K
NEUTRAL ★ 2/10
$12.15 $12.45▲ +2.47%▲ +2.79%$12.25 (+0.82%)
Aug 3, 2026
8w ago
6-K
BULLISH ★ 6/10
$12.07 $12.10▲ +0.25%▼ −1.55%$12.25 (+1.49%)
Jul 29, 2026
9w ago
6-K
NEUTRAL ★ 4/10
$11.76 $11.83▲ +0.60%▼ −1.08%$12.25 (+4.17%)
Jul 23, 2026
10w ago
6-K
NEUTRAL ★ 2/10
$11.80 $11.79▼ −0.08%▼ −0.19%$12.25 (+3.81%)
Showing 10 of 51

US Market Status

Market Closed — Opens Mon (65h 27m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access